Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Raymund Razonable and Dennis Bierle.
Raymund Razonable
Connection Strength
2.005
Dennis Bierle
  1. Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211019282.
    View in: PubMed
    Score: 0.922
  2. Reply to Puing et al. J Infect Dis. 2022 01 18; 225(2):353-355.
    View in: PubMed
    Score: 0.248
  3. Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
    View in: PubMed
    Score: 0.244
  4. Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
    View in: PubMed
    Score: 0.243
  5. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261.
    View in: PubMed
    Score: 0.233
  6. A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities. J Am Geriatr Soc. 2021 04; 69(4):868-873.
    View in: PubMed
    Score: 0.058
  7. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.